$MAC

The Macerich Company Q2 2026 Earnings Call Summary

Macerich reported progress on its Path Forward 3.0 plan, with leasing completion at 88% versus a midyear 85% target. Management reiterated 2026 go-forward portfolio NOI growth of at least 3%, accelerating to 3.5%+ in 2H, and expects >8% NOI growth in 2027-28 as a $140 million SNO pipeline contributes rent. Net debt/adj. EBITDA improved to 7.3x. The company plans $372 million of unsettled forward equity for acquisitions and noted a $76 million loan default at 29th Street.

Original reporting
Published Aug 7, 2026, 12:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Macerich Company Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$MACBullishMed
01

Why it matters

Management highlights ahead-of-schedule leasing progress (88% vs 85% midyear target), NOI growth targets (3%+ in 2026, 3.5%+ in 2H), and a 2027-28 ramp tied to a $140 million SNO pipeline. It also discloses net debt/adjusted EBITDA at 7.3x and ongoing discussions on a defaulted $76 million loan, plus plans to deploy $372 million in unsettled forward equity toward acquisitions with 9% to 11% stabilized yields.

02

Market read

Traders can update REIT cash-flow expectations based on explicit NOI growth targets, the pace of leasing conversion, and the planned use of forward equity, while monitoring the credit overhang from the disclosed loan default.

03

What to watch

The guidance depends on SNO pipeline conversion and permitting/construction timing; any delays would push the 2027-28 NOI ramp and the planned deleveraging path out.

Relevance 7/10Novelty 6/10Timing: ahead of the next trading session after the Q2 2026 earnings call

Background

This is a Q2 2026 earnings call summary for The Macerich Company, focused on Path Forward 3.0 execution, leasing conversion, guidance, and capital allocation.

Company-level read

Ticker impact

$MACBullishMedium confidence
Context

Macerich says Path Forward 3.0 is ahead of schedule, with 2026 go-forward NOI growth at least 3% and 2H acceleration to 3.5%+.

Expected impact

Near-term bias upward on earnings-call positioning, with follow-through dependent on whether the SNO pipeline converts and the 29th Street default is resolved.

Evidence & confidence

The article provides specific forward-looking targets (NOI growth, 2027-28 ramp, net debt/EBITDA) and capital allocation details (forward equity acquisitions), which can re-rate REIT cash-flow expectations. However, it also flags an ongoing loan default, which can cap upside if it worsens or forces asset-level actions.

Market effects

Reinforces the mall REIT playbook of converting signed-not-open pipeline into rent, using forward equity to fund acquisitions while deleveraging.

Tysons Corner and Scottsdale Fashion Square outperformance could support sentiment toward high-quality, traffic-generating submarkets.

Limited direct global linkage, but the discussion of higher-for-longer rates and refinancing assumptions informs broader commercial real estate capital-market expectations.

Counterpoint

The disclosed $76 million 29th Street loan remains in default, which could signal hidden credit stress that offsets the otherwise constructive NOI and conversion narrative.

Key entities

  • The Macerich Company

    REIT operator providing Path Forward 3.0 execution updates, 2026-28 NOI guidance, and capital allocation/deleveraging targets.

  • Tysons Corner

    Premier asset cited as showing late-stage transformation benefits with traffic and sales outperforming the portfolio average.

  • Scottsdale Fashion Square

    Premier asset cited alongside Tysons Corner for late-stage transformation outperformance.

  • Annapolis Mall

    Acquisition funded via a $450 million public offering, used as evidence of equity funding capability.

Related articles

$MACMedAI 8/10

Macerich Company: Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031

Macerich (NYSE: MAC) priced an upsized $675 million offering of 2.25% exchangeable senior notes due 2031, up from $600 million. The notes settle Aug. 11, 2026, pay 2.25% semiannually, mature Aug. 15, 2031, and are exchangeable into MAC shares at an initial rate of 35.4761 shares per $1,000 principal. Net proceeds are about $659.1 million.

$MACMed

Mall Giant Macerich Narrows Losses in Q2 Amid Stronger Leasing

Macerich (a mall REIT) reported Q2 leased occupancy of 94% (up from 92% a year earlier) after signing about 1.3 million sq ft of new and renewal leases. Lease revenue was $233.4M and total revenue $249.7M. Adjusted FFO was $100.4M. Net loss narrowed to $27.1M from nearly $41M, helped by asset sales. Go-forward NOI rose 3.8% and the company cited $1.2B liquidity.

$MACMed

MACERICH CO (MAC): Results of Operations and Financial Condition

MACERICH CO (MAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2-exhibit991.htm EX-99.1 2026 Q2- Exhibit 99.1 Exhibit 99.1 Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 2026 The Macerich Company Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 20

$MACMed

Macerich (NYSE:MAC) Stock Rating Upgraded by JPMorgan Chase & Co.

JPMorgan upgraded Macerich (NYSE:MAC) from “underweight” to “neutral” and set a $25.00 price target, implying 5.34% upside from the prior close, according to MarketBeat. Other firms cited include Deutsche Bank (to “buy,” $27 target) and Goldman Sachs (to “sell,” $19 target). Macerich reported $0.34 EPS and $241.54M revenue for Q ended May 6.

$MACMed

Macerich Announces Commencement of Public Offering of Common Stock

Macerich (NYSE: MAC) said it has started an underwritten public offering of 14,000,000 shares of common stock, with Goldman Sachs & Co. LLC as lead bookrunner. The underwriters have a 30-day option to buy up to 2,100,000 additional shares. Macerich expects to enter forward sale agreements with financial institutions; it will not receive initial proceeds, with net proceeds expected upon future settlement to fund acquisitions and general corporate purposes.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.